This is the authors' abstract. We don't add key points for this paper.
Brief communicationToxoplasma gondii (T.gondii) is a cosmopolitan zoonotic infection that affects a wide range of warm-blooded animals and is estimated to be over 30% of the human population to be seropositive worldwide [1,2].Beyond the socioeconomic and health consequences of toxoplasmosis, it is also considered an important abortifacient agent in farm animals that could cause significant economic damage to the field of animal farming in various countries [1,3].The routine medications prescribed to treat toxoplasmosis are insufficient due to their side effects and inability to remove bradyzoites within tissue cysts, thus vaccination strategies might be a good alternative to restrict T. gondii infection in domestic animals and humans, given its considerable global burden [4,5].In the past decades, several studies have been performed to evaluate the vaccine types through different strategies against acute and chronic toxoplasmosis worldwide [5,6].Overall, it is estimated that rhoptry proteins (ROPs) occupy about 1%-30% of the total parasite cell volume and participate in the formation and functional properties of the parasitophorous vacuole (PV) and PV membrane [7,8].
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Foroutan et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: